YUNNAN BAIYAO GROUP CO LTD

Yunnan Baiyao shares steady at CNY 53.61, 5% up month‑to‑date, amid stable 200‑day trend and growing pharma portfolio, promising health‑care growth.

Yunnan Baiyao (000538.SZ) steadies above its 200‑day SMA with 2.7% month‑to‑date growth, solid liquidity, and a low P/E—ideal for long‑term investors seeking resilience in China’s healthcare market.

Yunnan Baiyao shares stay flat at CNY 52.77, trading above the 200‑day SMA. The pharma stock’s 95.2 bn market cap and steady 2.88 % monthly rise show modest bullish momentum.

Yunnan Baiyao announces a 1.04 yuan per‑10‑share dividend, boosting its high‑yield appeal and showing strong cash flow for investors.

Yunnan Baiyao’s mid‑year dividend of 1.04 CNY per share—its highest payout of the year—signals strong earnings and a solid income play for investors in China’s healthcare sector.